,31 Although TVB-3166 has been shown to sensitize cancer cells to chemotherapy,24,25 the radiosensitizing efficacy of TVB-3166 has not previously been evaluated, and it appears from the current study that this FASN inhibitor does not radiosensitize in a similar manner to C75. Here, FASN is linked to cancer.